Sales and Marketing

Showing 15 posts of 11528 posts found.

Pfizer to acquire skin specialist firm Excaliard

November 28, 2011 Sales and Marketing EXC 001, Excaliard, Pfizer

Pfizer will acquire skin specialist Excaliard Pharmaceuticals as the firm looks to further diversify its pipeline. Financial terms of the …

The changing of the guard – Q3 round up

November 25, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy

 PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …

Mixed results for UK in international health survey

November 25, 2011 Sales and Marketing NHS, OECD, healthcare

The NHS in England does not perform well on some patient outcomes for cancer, stroke and respiratory diseases given the …
NICE hq pic

NICE okays Eliquis for blood clots after surgery

November 25, 2011 Research and Development, Sales and Marketing BMS, Eliquis, NICE, Pfizer

NICE is recommending Pfizer and Bristol-Myers Squibb’s Eliquis for blood clots after surgery. Specifically, NICE has said that Eliquis (apixaban) …
screen_shot_2011-11-24_at_13

RSA announces raft of new appointments

November 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

RSA, the global life sciences executive search and interim management firm, has announced a series of new appointments. RSA Switzerland …
glyn_edwards

Glyn Edwards appointed interim chief executive of the BioIndustry Association

November 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards

The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …
Lucentis image

Lucentis not backed by NICE for new licence

November 24, 2011 Sales and Marketing Lucentis, NICE, Novartis, Ozurdex

NICE has not recommended Novartis’ eye disease drug Lucentis due to ‘gaps and uncertainties’ in the manufacturer’s submission. In draft …
screen_shot_2011-11-24_at_09

Professor Sir Michael Rawlins reappointed as NICE chairman

November 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins

The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …

Private sector role in NHS commissioning opposed

November 23, 2011 Medical Communications, Sales and Marketing BMA, CCGs, NHS, PCT clusters

Private firms could be allowed to support clinical commissioning groups, the new NHS budget holders in England.New draft guidance from the Department …

Future of public health uncertain, says Forum

November 23, 2011 Sales and Marketing Future Forum, NHS, NHS reforms

The Department of Health has been urged to clarify the NHS’s responsibilities in relation to public health.The independent NHS Future …

Pfizer hatches mail order plan for Lipitor

November 23, 2011 Sales and Marketing Lipitor, Pfizer, US, generics

Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …
Vioxx

Merck pays $950 million to settle Vioxx charges

November 23, 2011 Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing

Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …

Pharmalink elects Anders Wiklund as its new board chairman

November 23, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pharmalink

Swedish speciality firm Pharmalink AB has elected Anders Wiklund to serve as its new chairman of the board. In addition …

Changes to the EMA’s registration process for SMEs

November 22, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized …
The Gateway to Local Adoption Series

Latest content


Five Facts about COPD

October 11, 2026